Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.61 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.58 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.58 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.58 |
| ▸ | PRKCA | P17252 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | MGLL | Q99685 | 1/20 | 0.56 |
| ▸ | CNR2 | P34972 | 1/20 | 0.55 |
| ▸ | TERT | O14746 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.53 |
| ▸ | BLM | P54132 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | FABP4 | P15090 | 2/20 | 0.53 |
| ▸ | FAAH | O00519 | 2/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.53 |
| ▸ | PPARG | P37231 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | PPARD | Q03181 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28936532 | 0.94 | TSHR (0.64) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL9348758 | 0.94 | TSHR (0.64) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL31203100 | 0.94 | TSHR (0.64) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL23576212 | 0.94 | TSHR (0.64) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL10084760 | 0.94 | TSHR (0.64) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL23576214 | 0.94 | TSHR (0.64) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL15027031 | 0.94 | TSHR (0.64) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL9348765 | 0.94 | TSHR (0.64) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL15027037 | 0.94 | TSHR (0.64) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL29269579 | 0.94 | TSHR (0.64) | DGKAPRKCEPRKCQPRKCDPRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226052-A1 | A SPECIFIC COMBINATION OF LIPIDS AND METHODS AND USES RELATED THERETO | HELSINGIN YLIOPISTO (FI) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240226052-A1 | A SPECIFIC COMBINATION OF LIPIDS AND METHODS AND USES RELATED THERETO | LIPA, MGLL, CETP | DGKA 319/4885PRKCE 2253/4885PRKCQ 1216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.